Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
10541
Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation
Published 2022“…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). …”
-
10542
Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation
Published 2022“…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). …”
-
10543
Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation
Published 2022“…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). …”
-
10544
Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation
Published 2022“…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). …”
-
10545
Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation
Published 2022“…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). …”
-
10546
Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation
Published 2022“…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). …”
-
10547
Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation
Published 2022“…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). …”
-
10548
Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation
Published 2022“…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). …”
-
10549
Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation
Published 2022“…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). …”
-
10550
Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation
Published 2022“…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). …”
-
10551
Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation
Published 2022“…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). …”
-
10552
-
10553
Data used for the analysis.
Published 2024“…Overall, the prevalence of schistosome infection was 55.9% (n = 2486, CI 95%: 53.3–58.5). A statistically significant association was found with age group (increased prevalence in 31–47 years old, compared to 16–20 years old (aPR = 1.15, CI 95%: 1.02–1.29) and with uptake of antimalaria preventive treatment (decreased prevalence, aPR = 0.85, CI 95%: 0.77–0.95). …”
-
10554
Demographics of the enrolled patients.
Published 2025“…Although the aid was designed to require minimal grip force, we measured the force needed to dispense a single drop for five commonly used clinical eye drops.…”
-
10555
Overhead view of the eye drop aid.
Published 2025“…Although the aid was designed to require minimal grip force, we measured the force needed to dispense a single drop for five commonly used clinical eye drops.…”
-
10556
Factors associated with schistosome infection.
Published 2024“…Overall, the prevalence of schistosome infection was 55.9% (n = 2486, CI 95%: 53.3–58.5). A statistically significant association was found with age group (increased prevalence in 31–47 years old, compared to 16–20 years old (aPR = 1.15, CI 95%: 1.02–1.29) and with uptake of antimalaria preventive treatment (decreased prevalence, aPR = 0.85, CI 95%: 0.77–0.95). …”
-
10557
-
10558
Image 5_Presurgical molecular therapy for renal cell carcinoma with venous tumor thrombus: a systematic review and meta-analysis.jpeg
Published 2025“…</p>Results<p>Overall, 184 patients were enrolled in this study. 30.7% (95% CI, 17.6–43.8%, I<sup>2</sup> = 79%, p<0.01) patients experienced a decrease in TT levels after receiving PMT, while only 1.5% (95% CI, 0–0.044%, I<sup>2</sup> = 0%, p=0.98) exhibited an increase in TT levels. …”
-
10559
-
10560